The Patent Finder

Terms ending in 2029

Irm LLC

Every in-force patent on Irm LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,507,488Fused Nitrogen Containing Heterocycles and Compositions Thereof as Kinase Inhibitors
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 8,178,563Compounds and Compositions as Hedgehog Pathway Modulators
In force
 · High confidence
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
US 8,552,002Compounds and Compositions as Protein Kinase Inhibitors
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,216,964Hedgehog Pathway Modulators
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 8,507,491Compounds and Compositions as Hedgehog Pathway Inhibitors
In force
 · High confidence
Novartis AGIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Irm LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited